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Conventional heart rate variability (HRV) indices comprise time domain and frequency
domain HRV indices that not only reﬂect the autonomic control of the heart but also serve as
prognostic markers of various cardiovascular disorders. These indices have been extensively
investigated as prognostic factors for patients who develop coronary artery diseases including
myocardial infarction (MI). Non-linear indices of HRV such as the long ()- and short (l,
and 2)-term fractal component indices and approximate entropy analysis have been
clinically applied. In addition, heart rate turbulence (HRT) and the deceleration capacity (DC)
of heart rate have been studied as potential HRV indices for predicting untoward outcomes of
cardiovascular diseases. This overview examines HRV indices and their roles in the setting
of cardiovascular disorders including sudden cardiac death. We describe changes in HRV
indices and clarify the relationship between prognosis and the indices in critically ill patients
admitted to intensive care units.
(J Arrhythmia 2010; 26: 227–237)
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Introduction
Autonomic control of the heart is an important
common pathophysiological pathway that connects
cardiovascular risk factors with the development
of cardiovascular disorders and the presentation of
cardiovascular symptoms.1–5) For example, changes
in cardiac autonomic activities are important mod-
ifying factors that induce lethal cardiac arrhythmias
(ventricular tachycardia and/or ventricular ﬁbrilla-
tion). Heart rate variability (HRV) is an established
clinical method of evaluating the degree to which
autonomic control of the heart is impaired.6–8)
In addition, many basic and clinical studies
have shown that HRV indices reﬂect autonomic
control of the heart, but they could also serve
as prognostic markers of a wide range of cardio-
vascular disorders, from less lethal condi-
tions (hypertension and uncomplicated diabetes
mellitus) to myocardial infarction and heart fail-
ure.9–15)
This overview examines the various types of
HRV indices and their roles in predicting the
prognosis of cardiovascular diseases. Lastly,
the relatively new concept of the role of HRV
indices in intensive care medicine is further dis-
cussed.
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Various type of HRV indices
Table 1 shows the various types of HRV indi-
ces.16–20) Conventional HRV indices include time
domain and frequency domain. These indices are
derived from the software provided with 24-h Holter
electrocardiography (ECG) instruments. Figure 1
shows the most popular methods that are used to
calculate frequency domain HRV indices.6) The
RR intervals of the normal sinus rhythm are plotted
against time to obtain tachograms of the RR intervals
on electrocardiograms. Power spectral density is
then mathematically derived from tachograms using
fast Fourier Transport (FFT), maximum Entropy
Method (MEM) and autoregressive analysis (AR).
Each frequency power spectral density is plotted
against frequency. Conventional indices of low
(0.04–0.15Hz), high (0.15–0.40Hz), and total
(0.001–0.50Hz) frequency spectra are thus deter-
mined. The ratio of the low to the high frequency
(LF/HF) spectra is considered as a relative index of
sympathetic activity, whereas high frequency spectra
reﬂect the activity of the vagal nerve to the heart.
This concept of the relationship between low and
high frequency spectra to autonomic nerve activity
and the heart is obtained from observing the behav-
ior of each low and high frequency spectral response
to postural shifts such as a change from supine to
standing (Figure 2),6,21) as well as to pharmacological
intervention by administering sympathetic (propra-
nolol) and vagal (atropine) blockades.22) Figure 3
summarizes the proposed relationship between pow-
er spectral density and neural control of the heart.
Although many studies have used LF/HF as the
Table 1 Heart rate variability indices
1)
1. Time domain analysis
SDNN
SDANN
SD mean (SD index)
pNN50
rMSSD
2. Frequency domain analysis
By using FFT, MEM, AR
Total freqeuncy spectra (TF, 0.0001–0.50Hz)
Ultra low frequency spectra (ULF, 0.0001–0.003Hz)
Very low frequency spectra (VLF, 0.003–0.04Hz)
Low frequency spectra (LF, 0.04–0.15Hz)
High frequency spectra (HF, 0.15–0.40Hz)
LF/HF
2)
3. Geometrical methods
Triangular Index
Lorenz plot
4. None linear methods
Long term fractals; ()
Detrended Fluctuation Analysis;
Short term fractals, (1), (2)
Approximate entropy
5. New methods
Heart rate turbulence; HRT
Deceleration capacity of heart rate: DC
Conventional (1) and relatively new (2) measurements of
heart rate variability indices.
ECG Tachogram of RR interval on ECG
FFT,  MEM
AR
Power spectral density (PSD) Power spectra indices
Figure 1 Methods of deriving or calculat-
ing frequency domain heart rate variability
indices (power spectral density).
FFT: fast Fourier transport, MEM: maximum
entropy method, AR: autorecessive method
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sympathetic index of the heart, this concept has been
criticized. Eckberg ﬁrst criticized this concept of
LF/HF as a sympathetic index of the heart.23) We
investigated24) whether LF/HF really reﬂects the
sympathetic activity of the heart by measuring the
norepinephrine overﬂow rate from the heart under
handgrip testing. We compared the low and high
frequency spectra and the LF/HF with changes in
Supine Supine
Standing Standing
Sympathetic ↑ Parasympathic ↓
Figure 2 Changes in power spectral density induced by
postural changes.
Postural change from supine to standing induces relative increase
and decreased in low and high frequency spectra, respectively.
These changes suggest that increasing sympathetic activities
together with decreasing parasympathetic activities cause signiﬁ-
cant changes in spectral density.
Sympathetic
Parasympathic
LF/HF ratio could be the marker of pure sympathetic activity
Figure 3 Features of power spectral densities on each
frequency band and relationships between sympathetic and
parasympathetic activities and each power spectrum.
There is a little 
concern that 
LF/HF is a real 
sympathetic 
index of the 
heart
ΔNE x CSBF x 100-Ht/100
(Norpinephrine spill over) VS. HRV
Figure 4 Correlation between low and high frequency spectra and cardiac sympathetic activities derived
from thermodilution catheter placed in cardiac coronary sinus.
NE: norepinephrine, CSBF: coronary sinus blood ﬂow, HRV: heart rate variability, LF/HF: low and high frequency
spectral ratio
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cardiac norepinephrine overﬂow rate during the test.
Figure 4 shows a signiﬁcant but relatively weak
correlation between LF/HF and changes in cardiac
norepinephrine overﬂow rate, suggesting that LF/HF
is limited as a marker of sympathetic activity to the
heart. This limitation should be considered when
LF/HF is used as a sympathetic index of the heart in
clinical studies when power spectral HRV indices
are applied to evaluate the autonomic activity of the
heart.
Geometric and non-linear methods, as well as
heart rate turbulence and the deceleration capacity
of heart rate, have recently been proposed as HRV
indices (Table 1). Malik et al. shows the popular
geometrical method of obtaining the triangular index
(TI).25) The most suitable triangular shape is ﬁt to the
RR interval histogram of normal sinus beats and then
the area of the triangle is measured. The TI has been
extensively studied by Malik et al.25) in a large study
cohort. Cutoﬀ values of both 16 and 19 units have
been proposed. The non-linear HRV indices,19) long-
term fractal , and short-term fractal indices 1 and
2 derived from detrended ﬂuctuation analysis and
the approximate entropy method have been applied.
These HRV indices are based on the notion that the
‘‘HRV behaves in a fractal manner’’ (Figure 5).
Role of HRV indices for predicting the prog-
nosis of cardiovascular disease
The HRV index was initially recognized as a
prognostic marker in the coronary care unit by Wolf
et al. in 1978.26) They monitored the electrocardio-
grams of patients with acute myocardial infarction
A
B
C
Figure 5 Scheme of fractal concept.
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Figure 6 Impact of heart rate variability on survival after myocardial infarction.
Impact of time (1) and frequency (2) domain heart rate variability on survival rates after acute myocardial infarction.
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and found that the prognosis of patients with a lower
standard deviation (SD) of normal sinus rhythm
RR intervals on electrocardiograms was poor. The
in-hospital mortality rates were 3-fold higher among
patients with acute myocardial infarction and SD
of <10ms than among those with SD 10ms. In
contrast, the relationship between HRV indices and
autonomic dysregulation of the heart was discovered
in diabetic neuropathic patients by Wheeler and
Watkins in 1973.27) Nine years later in 1987, Kleiger
et al.9) studied a relatively large (>800) cohort of
patients in a multi-center post-infarction research
A B
(M.T. OMI, 2VD, 75y/o )
Figure 7 Case of sudden cardiac death.
Temporal decrease in heart rate variability index and increase in frequency of silent myocardial ischemic episodes
before sudden cardiac death.
A B C
Y=-1.70X-1.20
Y=-1.24X+1.25
Y=-1.07X-1.78
Figure 8 Heart rate variability as therapeutic
marker for medication in heart failure.
Eﬀect of  blocker therapy on long term fractal 
value.
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group. They proposed cutoﬀ values of 50 and 100ms
for the SD of the normal sinus RR interval over
24 h of Holter ECG monitoring. The mortality rates
over 1 year of follow-up after acute myocardial
infarction were 7-fold higher among patients with
SD (SDNN) <50ms than SD >100ms. The mortal-
ity rates among patients with SD 50–100ms were
about in the middle of those of the other two groups.
Martin et al.28) reported that decreased time domain
HRV indices in patients with coronary artery disease
indicate increased risk of sudden cardiac death even
within a small cohort. Many subsequent reports
suggested that both time domain and frequency
domain HRV indices could identify problematic
outcomes in patients with coronary artery disease
(Figure 6).9,29,30) Several other reports show that
decreased HRV indices suggest a poor prognosis
not only for patients with coronary artery disease
but also a wide range of cardiovascular diseases
such as hypertension, heart failure and arrhythmia.
We experienced a patient with coronary artery
disease who had a temporal decrease in the HRV
index and an increasing frequency of silent myo-
cardial ischemic episodes that resulted in sudden
cardiac death (Figure 7).10) TI has also been reported
as a prognostic marker for patients with myocardial
infarction.25) Recent reports show that non-linear
HRV indices such as long-term fractal 31) and short-
term fractal 1 and 232,33) are also good markers of
poor prognosis among patients with cardiovascular
Turbulance onset (TO, %) = [(RR1+RR2)-(RR-3+RR-2)]/(RR-3+RR-2) x 100
Turbulance slope (TS, ms/beat) ; After PVC, Linear regression of 5 beat RR interval 
Class 0 = Normal    ; TO<0% and TS>2.5 ms/beat
Class 1 = Abnormal; TO>0% or TS<2.5 ms/beat
Class 2 = Abnormal; TO>0% and TS<2.5 ms/beat
A B
Figure 9 Measurement, indices and criteria of heart rate turbulence.
Measuring heart rate turbulence and abnormal criteria (1); theoretical background of heart rate turbulence
measurements (2).
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diseases as well as being useful markers of the
outcomes of pharmacological intervention.31)
Figure 8 shows that  blocker therapy improved
heart failure and the long-term fractal  value. Any
decreased HRV indices are presently recognized as
indicators of a poor prognosis for patients with
cardiovascular diseases.19,32,33)
Two newer powerful predictors of HRV indices
are heart rate turbulence (HRT)34–39) and the decel-
eration capacity (DC) of heart rate.40,41) Heart rate
turbulence can be obtained from RR behavior after a
ventricular premature beat (Figure 9). The basic
mechanisms are related to baroreﬂex sensitivity.
Simple ectopic beats provoke transient increases
in sympathetic neural activity that is directly related
to the magnitude of hypotension and inversely
related to coupling interval. High-frequency ectopy
can increase sympathetic nerve activity and thus
might increase the risk of sudden cardiac death by
altering the autonomic milieu (as opposed to simply
reﬂecting an altered substrate for arrhythmias). The
eﬀect of ectopy on parasympathetic activity is
unknown. However, parasympathetic activity re-
sponses probably mirror sympathetic nerve activity
responses as predicted by the baroreﬂex-mediated
eﬀect. Many multi-center randomized clinical trials
have found that HRT is one of the most powerful
indices of a negative outcome for patients with
myocardial infarction (Figure 10).39) Schmit et al.
recently proposed that DC is more powerful pre-
dictor than the other non-invasive parameters in
terms of predicting a poor prognosis in patients
with myocardial infarction.40) They suggested that
TO
 &
 T
S 
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no
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MPIP
EMIAT
ATRAMI
ISAR HRT
1 3 5 7 9 Relative risk
Relative risk (multivariate analyses) for the 
MPIP, EMIAT, ATRAMI, and ISAR-HRT populations
Francis J et al ANE 2005;10:102
Figure 10 Clinical signiﬁcance of heart rate turbulence in randomized clinical trials (RCT).
Relative risk for each RCT.
P-Surg CAD
Mean±SD
  p<0.05 vs CAD
(-1 x)
0.5
1.0
1.5
2.0
2.5
Figure 11 Comparison of non-linear heart rate variability
index of long term fractal  between patients after surgery in
intensive care and those with chronic stable angina.
Abbreviations are as described in the legend to Figure 14.
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impaired heart rate deceleration capacity is a power-
ful predictor of mortality after myocardial infarction
that is more accurate than left ventricular ejection
fraction and the conventional HRV indices.
Role of HRV indices in intensive care medicine
A signiﬁcant role of HRV indices for patients in
intensive care has been reported.20,42–47) Decreased
HRV indices reﬂect a poor prognosis for trauma
patients. The role of HRV indices on the prognostic
impact for intensive care patients has also been
discussed in Japan.47)
We performed a preliminary study of the features
of HRV indices in the intensive care unit (ICU) and
then investigated the relationships among HRV
indices, Acute Physiologic Chronic Health Evalua-
tion (APACHE) scores46) and serum cytokine and
catecholamine levels.
The preliminary study enrolled 11 post-surgical
patients who required care in the ICU and 14 patients
with chronic stable angina. The time and frequency
domain HRV indices and long-term fractal  values
were derived from 24-h ECG monitoring. As a
result, all time and frequency domain HRV indices
were signiﬁcantly lower in the post-surgical patients
in the ICU than in those with chronic stable angina.
In addition, long-term fractal  was worse in the
post-surgical patients than in those with chronic
stable angina (Figure 11). In summary, conventional,
as well as non-linear HRV, indices among patients in
the ICU were signiﬁcantly lower than in patients
with chronic eﬀort angina. Since patients in the ICU
have impaired cardio-circulatory status, these results
suggest that HRV indices in the ICU can reﬂect
patient status and that they might serve as prognostic
markers for such patients as they do for patients with
cardiovascular disease.
The second study investigated correlations among
HRV indices, APACHE prognostic score, cytokines
and catecholamines among patients in intensive
care.47) The study population comprised 80 patients
in our ICU among whom 56 (age, 65 12 years) had
acute coronary syndrome (ACS) and 24 (age, 66
12 years) were post-surgical patients with cardio-
vascular complications. At the time of ICU admis-
sion, serum cytokine and catecholamine levels were
measured in the peripheral blood. Cytokines includ-
ing IL-1b, IL-4, IL-6, IL-8, IL-10, IL-12, IL-13,
IL-15, IL-17, G-CSF, INF-, TNF- and MIP-1
were measured using the Bio-Plex Suspension Array
System. Catecholamines comprised norepinephrine,
epinephrine, and dopamine levels. The HRV indices
obtained from 24-h ECG monitoring, conventional
time and frequency domain HRV indices, long-term
fractal  values and APACHE scores were calcu-
lated. Table 2 lists the known clinical functions of
each cytokine,48) and the measurement and clinical
features of the APACHE score are explained in
Figure 12 by citing the original article. The present
Table 2 Cytokine functions
Cytokines Location within Cell Function
IL-1 Monocyte, Macrophage, B cell, T
cell, NK cell
Excreted from macrophage and induce acute phase of
inﬂammation
IL-4 T cell, Mast cell, Basocyte Induce the growth of B cell and the differentiation of T cell andMast cell (relating production of IgE)
IL-6 Monocyte, Macrophage, B cell, T
cell, Endothelial cell
Stimulate Marcophage and induce acute inﬂammatory
reaction
IL-8 Monocyte, Lymphocyte, Granulocyte Activate chemotaxis of polynuclear cells ! Promote
angiogenesis
IL-10 T cell, B1B cell, Macrophage Inhibits the production of Th1 cytokines
IL-12 B cell, Macrophage Stimulate NK cell and induce Th1 cell
IL-13 Active CD4þ T cell Similar to IL-4,IgE production and inhibit inﬂammatory cytokines
IL-15 Monocyte, epithelial cell, Muscle cell Growth and differentiate T cell
IL-17 CD4þ T cell Induce the production of inﬂammatory cytokines
G-CSF BMC stroma cell, monocyte Growth, activate and differentiate pro-granulocyte andgranulocyte
TNF- Monocyte, Macrophage, B cell,T cell Related to fever and septic shock
Red and blue font indicates inﬂammatory and anti-inﬂammatory cytokines, respectively.
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results revealed that both long-term fractal  and
plasma levels of norepinephrine signiﬁcantly corre-
lated with APACHE score (r ¼ 0:30, P < 0:01 and
r ¼ 0:32, P < 0:01, respectively). The HRV indices,
total spectral density and very low-frequency spectra
signiﬁcantly correlated with IL-12 (r ¼ 0:35, and
r ¼ 0:39, respectively, P < 0:01), a pro-inﬂamma-
tory cytokine that is associated with B-cells and
macrophages. Because the APACHE score is a
surrogate marker of prognosis, one of the HRV
indices, long-term fractal  and sympathetic activity
that reﬂects epinephrine levels, might be associated
with a poor outcome among patients in intensive
care. In addition, the total spectrum and/or very low
frequency spectra might serve as a powerful prog-
nostic predictor of cardiovascular events. Since total
and very low-frequency spectra signiﬁcantly corre-
lated with the inﬂammatory cytokine IL-12, it might
be associated with a poor prognosis for patients in
intensive care. Long-term fractal  also signiﬁcantly
correlated with the stress-related marker of epi-
nephrine levels and thus might be associated with
poor prognosis through a stress-mediated mecha-
nism.
Since following HRV indices signiﬁcantly corre-
lated with IL-12 and sympathetic activity, total and
very low frequency spectra could be further topics of
interest in a future study.
In summary, HRV indices including long-term
fractal , total and very low-frequency spectra, as
well as levels cytokines including pro-inﬂammatory
IL-12 and catecholamines such as norepinephrine
and epinephrine, might be associated with a poor
prognosis for patients in intensive care.
Since measuring HRV indices might provide
prognostic and pathophysiological information about
APACHE III AND HOSPITAL DEATH RATE FOR
891 CONGESTIVE HEART FAILURE PATIENTS
APACHE III AND HOSPITAL DEATH RATE
FOR 1,467 ICU TRAUMA ADMISSIONS
High APACHE III 
score indicates
poor prognosis
WA Knaus et al.
Chest 1991;100;1619-1636
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DEATH RATE N OF CASES
Figure 12 Calculation of APACHE III scores.
Methodological details of calculating APACHE III scores.
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patients with cardiac complications in intensive care,
further clinical studies are required to conﬁrm our
ﬁndings.
Conclusions
Each of the various types of HRV indices is
clinically useful for understanding the autonomic
imbalance of the heart and for predicting the
prognosis of patients with cardiovascular diseases.
The role of HRV indices could become increasingly
signiﬁcant if more clinical studies could conﬁrm
their role in intensive care medicine.
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